---
title: "Dynavox Q4 revenue rises 16% to SEK 677 million"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/274923640.md"
datetime: "2026-02-05T06:30:39.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/274923640.md)
  - [en](https://longbridge.com/en/news/274923640.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/274923640.md)
---

> Supported Languages: [简体中文](https://longbridge.com/zh-CN/news/274923640.md) | [繁體中文](https://longbridge.com/zh-HK/news/274923640.md)


# Dynavox Q4 revenue rises 16% to SEK 677 million

Dynavox Group AB reported record results for the fourth quarter (Q4) and full year (FY) 2025. Q4 revenue rose 16% to SEK 677 million, with an operating profit of SEK 103 million and an operating margin of 15.2%. Gross margin was 69% for the quarter. Basic earnings per share reached SEK 0.72. For the full year 2025, revenue increased 25% to SEK 2,467 million. Operating profit for the year totaled SEK 254 million, corresponding to an operating margin of 10.3%. Gross margin for the year was 68%. Basic earnings per share for the period was SEK 1.57. Cash flow after continuous investments was SEK 46 million in Q4 and SEK -9 million for the full year. The Board of Directors proposes a dividend of SEK 0.5 per share for the fiscal year. On the business front, Dynavox Group entered into an agreement to acquire all shares of its Italian reselling partner, SR Labs Healthcare. The company reported robust demand across its product portfolio, highlighting continued strong sales momentum in touch-controlled solutions for younger users with autism and growing traction for eye-gaze controlled solutions targeting individuals with complex needs. The CEO noted that the company remains well-positioned in an underpenetrated market, with a focus on sustainable growth and advancing communication solutions. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Dynavox Group AB published the original content used to generate this news brief via Cision (Ref. ID: 20260205:BIT:6444:0) on February 05, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT)

### Related Stocks

- [Dynavax Technologies Corporation (DVAX.US)](https://longbridge.com/en/quote/DVAX.US.md)

## Related News & Research

- [Artelo Biosciences announces reverse stock split](https://longbridge.com/en/news/278123999.md)
- [MAHA's sweeping vaccine changes and social media have parents more confused than ever](https://longbridge.com/en/news/278099569.md)
- [Uncovering Potential: Zevra Therapeutics's Earnings Preview](https://longbridge.com/en/news/278126364.md)
- [Fulcrum Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | FULC Stock News](https://longbridge.com/en/news/278172807.md)
- [Novartis shareholders approve all resolutions proposed by the Board of Directors at the 2026 Annual General Meeting](https://longbridge.com/en/news/278108004.md)